The 2026 Healthtech Messaging Index

Rank#70of 302

Akasa

akasa.com·scored November 1, 2026

63out of 100

24/38

Approaching

Close. The bones are good. A few targeted fixes on the weakest signals would push Akasa into magnetic territory.

ApproachingAI recommends them? Yes
Akasa homepage

The page we scored

The AI Recommendation Check

When we asked AI who to recommend for AI-powered autonomous medical coding and revenue cycle management software for health systems, it named:

Buyer we put in the prompt: VP of Revenue Cycle or Chief Financial Officer at a U.S. health system or hospital network. Both the buyer and the category were inferred from Akasa’s homepage alone. The model had no web access.

Optum3603M Health Information SystemsNuance CommunicationsOlive AIWaystarCoding IntelAGS Health

Akasa was on the list.

AI named them for their own category. That's the signal every homepage is supposed to send.

AI mentioned you for "AI-powered autonomous medical coding and revenue cycle management software for health systems", but only generically: "AKASA is an AI-driven revenue cycle automation company that applies machine learning to automate medical coding and other RCM workflows for health systems.". You're on the radar, but AI doesn't yet repeat your specific positioning back.

Overall assessment

AKASA's biggest strength is specific, mechanistic AI claims backed by concrete numbers (65 ... 85% autonomous volume, 1 in 10 U.S. discharges) and genuinely owned category language ('autonomous mid-cycle') that an LLM could cite distinctly. The biggest gap is the complete absence of buyer problem leadership and alternatives acknowledgment ... the page never names the pain a revenue cycle leader is living before pitching the solution, and never addresses competing approaches (offshore coders, incumbent vendors, do-nothing), which leaves buyers without the emotional resonance needed to act.

Signal by category

Narrative Clarity

8 signals

9/16

Trust Signal

4 signals

4/8

AI Signal

6 signals

10/12

Conversion Signal

1 signal

1/2
0

Weakest signal · fix this first

05Problem Leadership

“The autonomous mid-cycle is here. Finally.”

The page leads with a solution declaration and category announcement, not the buyer's problem ... there is no articulation of the buyer's pain before the pitch begins.

All 19 signals, scored 0 to 2.

Narrative Clarity

8 signals

9/16
  • 01The 7-Second Test

    “The autonomous mid-cycle is here. Finally.”

    The hero declares a category moment but doesn't immediately answer who it's for or what problem it solves ... a stranger wouldn't know this is for hospital revenue cycle teams without reading further.

    1
  • 02Rebellion / Movement

    “Health systems should get full credit for the care they deliver.”

    There's an implicit enemy (underpayment, inaccurate coding) but no named status quo, named competitor pattern, or explicit rebellion statement ... the grievance is implied, not declared.

    1
  • 03Owned Language & Category

    “The autonomous mid-cycle is here." / "autonomous coding, built for inpatient complexity”

    AKASA coins 'autonomous mid-cycle' and 'autonomous coding' as distinct owned terms in a specific category frame that AI could cite back uniquely.

    2
  • 04ICP Clarity

    “We build AI for the hardest work in the revenue cycle.”

    Health systems are implied but role (CFO, VP Revenue Cycle, coding director), size, or stage is never specified, leaving ICP partially visible but not crisp.

    1
  • 05Problem Leadershipweakest

    “The autonomous mid-cycle is here. Finally.”

    The page leads with a solution declaration and category announcement, not the buyer's problem ... there is no articulation of the buyer's pain before the pitch begins.

    0
  • 06Solution Clarity

    “AKASA reads and reasons across the complete patient record, applies your health system's coding standards, and autonomously codes the encounter with the evidence behind every code.”

    That single sentence clearly and repeatably explains what AKASA does ... a visitor can parrot it back after one read.

    2
  • 07Cost of Inaction

    “Health systems should get full credit for the care they deliver.”

    The page implies revenue leakage but never names the dollar cost, operational consequence, or competitive risk of not acting ... stakes are gestured at, not quantified.

    1
  • 08Promised Land

    “More complete documentation, more accurate coding, and more capacity for your teams.”

    The promised land is stated but generic ... no specific 'after' scenario (e.g., days in AR reduced by X, coder headcount freed) makes it vivid or ownable.

    1

Trust Signal

4 signals

4/8
  • 09Proof & Evidence

    “65 to 85% of inpatient volume at most health systems autonomously addressable" / "1 in 10 U.S. inpatient discharges”

    Multiple concrete numeric claims with sourcing context (blinded third-party evaluation, AKASA survey) give real proof points, not just adjectives.

    2
  • 10Social Proof

    “AKASA and Methodist Health System: Getting More Pennies on the Dollar With Automation from AKASA”

    One named customer video exists and Cleveland Clinic is referenced in a blog title, but there are no named testimonials with titles, no quote pull-outs, and no logo wall on the homepage.

    1
  • 11Authority & Credibility

    “AKASA Named Among Fastest Growing Generative AI Startups to Watch”

    A press mention and an AHIMA conference announcement signal credibility, but no founder credentials, original research reports, or frameworks are surfaced on the homepage itself.

    1
  • 12Alternatives Acknowledged

    “No mention of competitors, manual coding, outsourced coding vendors, or 'do nothing' as an alternative anywhere on the page.”

    The page never acknowledges the buyer's other options ... competing vendors, offshore coding teams, or status quo staffing ... making it impossible to self-select or feel understood.

    0

AI Signal

6 signals

10/12
  • 13Customer Focus

    “Health systems should get full credit for the care they deliver.”

    The page opens with a customer-oriented framing but quickly pivots to product features and company stats, making the company the protagonist for most of the scroll.

    1
  • 14AI-Parmesan Index

    “AKASA builds a custom AI model for your health system, trained on your own clinical documentation, case mix, and coding decisions.”

    AI claims are mechanistic and specific ... custom model training on client-specific data, tuned to payer rules and documentation patterns ... not vague 'AI-powered' sprinkle.

    2
  • 15LLM Quotability

    “AKASA reads and reasons across the complete patient record, applies your health system's coding standards, and autonomously codes the encounter with the evidence behind every code.”

    That sentence is clean, declarative, and specific enough that an LLM could lift it verbatim to describe what AKASA does in a recommendation.

    2
  • 16Copyright Freshness

    “Copyright 2026 AKASA Inc." / "NEW! ANNOUNCED AT AHIMA26”

    Copyright year is 2026 and a fresh conference announcement is prominently flagged, giving AI recency signals that the content is current.

    2
  • 17Entity Distinctiveness

    “The autonomous mid-cycle is here." / "1 in 10 U.S. inpatient discharges" / "custom AI model for your health system, trained on your own clinical documentation”

    The combination of owned category language ('autonomous mid-cycle'), inpatient-specific focus, custom per-health-system model training, and the 1-in-10 discharge stat makes AKASA distinctly attributable versus generic RCM AI competitors.

    2
  • 18AI Recommendation Check

    “AI named you alongside Optum360, 3M Health Information Systems, Nuance Communications, Olive AI, AKASA, describing you as: "AKASA is an AI-driven revenue cycle automation company that applies machine learning to automate medical coding and other RCM workflows for health systems.".”

    AI mentioned you for "AI-powered autonomous medical coding and revenue cycle management software for health systems", but only generically: "AKASA is an AI-driven revenue cycle automation company that applies machine learning to automate medical coding and other RCM workflows for health systems.". You're on the radar, but AI doesn't yet repeat your specific positioning back.

    1

Conversion Signal

1 signal

1/2
  • 19Path & CTA Clarity

    “START WITH INPATIENT CODING" / "REQUEST A DEMO" / "FIND OUT MORE”

    There is a primary CTA and a soft secondary, but no visible numbered process or clear path explaining what happens after you click ... the CTAs exist but aren't connected to a shown journey.

    1

Keep the lead

AI already names Akasa. The next edition decides if it still does.

Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Akasa the AI recommendation, and what to write instead.

Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.

← Back to the full Healthtech index

We revamp websites that ChatGPT ignores.

See the 90-Day AI Website Rebuild →